Skip to main content
Philanthropy Journal Home

Philanthropy Journal News

Talecris awards $1 million


Alpha-1 Foundation to receive up to $1 million in matching funds from Talecris Biotherapeutics for research into alpha-1 antitrypsin deficiency, genetic condition that can lead to emphysema.

Leave a Response

Your email address will not be published. All fields are required.